SLC3A2 and hepatocellular carcinoma: The present study has demonstrated that lncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway through upregulating SLC3A2 and its nuclear overexpression is promoted by miR-21 in HCC cells.